logo
Thinking about getting a tattoo? Here's what you should know

Thinking about getting a tattoo? Here's what you should know

CBC14-04-2025

Tattooing services are regulated and largely considered safe, but there's a growing group of experts concerned over links between tattoo ink and allergic reactions, as well as potential associations between tattoos and certain kinds of cancer.
Current evidence largely shows associations — not causation — with cancer, but experts say people should be aware that tattoos do come with a small amount of risk, even if more research is needed to determine the severity of that risk.
What are the risks of getting a tattoo?
Tattoos are permanent because they're formed when a needle containing ink pierces skin and deposits the pigment in the dermis — the skin's middle layer — according to Dalhousie University dermatologist Dr. Kerri Purdy.
The needle being dipped into ink and then penetrating the skin increases the risk of certain infections — like mycobacterial infections — as well as introduces the possibility of spreading diseases like hepatitis and HIV.
"That said, the risk is exceedingly low, with people and tattoo parlours being very careful about that," said Purdy, division head of clinical dermatology and cutaneous science at Dalhousie's school of medicine.
A 2025 two-part series on tattoo-associated infections published in the Lancet Microbe found that the risk of infection ranged from study to study.
In general, roughly one to six per cent of tattooed people experienced a microbial infection after receiving a tattoo, though it's not uncommon for people to experience minor skin elevation or itchiness after a fresh tattoo.
Tattoo infections are often mild to moderate, with the second paper in the two-part series explaining that tattooing can lead to life-threatening infections in "rare and extreme cases."
Purdy says people can develop allergic reactions to compounds present in the ink itself, once the ink makes it into our skin.
Western University chemist Yolanda Hedberg's 2021 study analyzed more than 70 tattoo ink samples, finding traces of potentially harmful metals like nickel and chromium in almost all of the samples tested.
Arsenic, mercury and lead all turned up in one sample each.
The study samples were collected both in-person and online from vendors in Sweden, but many of the ink samples were fabricated in the U.S. and are commonly available in many countries, including Canada.
The study found that 93 per cent of the inks tested violated European labelling requirements. Researchers concluded that 61 per cent of inks contained "pigments of concern," but found that the level of metal exceeded restriction limits in "only a few cases."
Hedberg added that the ingredients listed on an ink bottle didn't always match up with the actual ingredients in the ink itself.
Different tattoo inks also present different levels of risk, she says. For example, certain red inks contain azo dyes, increasing the allergic risk. Azo dyes are synthetic and do not occur naturally. Many are non-toxic, though some azo dyes are mutagens and carcinogens.
While tattoo allergies can develop within days of inking, Hedberg says it's not uncommon for tattoo allergies to develop after several weeks or even months, rather than immediately after inking.
The delay likely occurs because it takes time for the body to identify the tattoo as foreign material that needs to be removed. "Generally, you would notice an allergic reaction within three months," she said.
Mild cases of tattoo allergies can be treated using topical steroid creams.
More significant or swollen allergic reactions can be treated using corticosteroidal injections, while very severe reactions can require medications like prednisone, according to Purdy.
What does the research show about cancer?
A small number of studies have tracked a potential association between tattoos and the development of certain cancers, including melanoma and lymphoma.
A 2025 study of Danish twins found that the risk of skin cancer was 1.62 times higher among people with tattoos. The study looked at twins where one sibling had a tattoo and the other didn't, comparing the health of each twin.
The study sampled 2,367 randomly selected twins and a control group of 316 twins, all born between 1960 and 1996. The risk was determined for tattoos that were larger than the palm of a hand.
The study identified the lack of information on sun exposure as a possible limitation. Additionally, the study didn't look at factors like how many cigarettes were smoked by study participants.
Another study published in the Lancet in 2024 compared almost 1,400 people who had lymphoma to almost 4,200 people who didn't, finding that 21 per cent of the people with lymphoma had tattoos.
Nonetheless, the 2024 study found an association, not direct causation. The authors concluded that more research is needed to establish causality.
McGill University dermatologist Dr. Elena Netchiporouk says the core compound required to produce black ink — a compound known as carbon black — is a possible carcinogen derived in part from the incomplete combustion of petroleum products.
"We know that [carbon black] has very strong proof that it can cause cancer in humans," said Netchiporouk, speaking with The Dose 's Dr. Brian Goldman.
Netchiporouk — who wasn't involved in the 2025 Danish study or the 2024 Lancet study — cautioned that current carcinogenic evidence comes from research on ingesting carbon black, not from injecting it into our skin.
She also said darker tattoos can also make it difficult to monitor for signs of skin cancer — especially if tattoos cover up moles.
It's not clear whether the size of someone's tattoos increase their cancer risk.
Netchiporouk says more research is necessary to determine the true cancer risk associated with tattoo inks.
What should I do if I'm worried?
Purdy recommends that anyone interested in getting a tattoo visit a reputable tattoo shop.
Tattoo parlours are regulated by provincial and territorial governments in Canada, while tattoo inks are subject to cosmetic regulations under the federal Food and Drugs Act.
"It is the responsibility of the manufacturer or importer to meet the requirements of the Food and Drugs Act and Cosmetic Regulations and ensure that the product they are selling is safe," Health Canada wrote in an email statement.
Still, Hedberg says Canada's tattoo regulations are less stringent than Europe's rules.
WATCH | Why doesn't New Brunswick have regulations for tattoo shops?
Why doesn't New Brunswick have regulations for tattoo shops?
1 year ago
Duration 3:16
With the popularity of tattoos growing, one New Brunswick tattoo artist is sounding the alarm over the lack of provincial regulations governing the practice.
The EU banned in 2022 thousands of chemicals used in tattoo inks, which has affected certain blue and green pigments.
"In Canada, you can still tattoo all colours and they are not restricted here just yet," said Hedberg.
Netchiporouk says laser tattoo removal is usually a safe option.
However, she notes that the azo dyes typically present in red inks can undergo transformation because they're sensitive to ultraviolet radiation, as well as laser removal.
"They can transform into other chemicals in the skin, which can become more likely allergenic," said Netchiporouk.
Due to the questions surrounding tattoos, Netchiporouk isn't interested in getting one any time soon.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The BC Centre for Excellence in HIV/AIDS national Summit raises alarm about rising incidence of HIV in Canada and threats to global progress
The BC Centre for Excellence in HIV/AIDS national Summit raises alarm about rising incidence of HIV in Canada and threats to global progress

Cision Canada

time14 hours ago

  • Cision Canada

The BC Centre for Excellence in HIV/AIDS national Summit raises alarm about rising incidence of HIV in Canada and threats to global progress

Delegates call on Prime Minister to end the Canadian epidemic and lead the worldwide HIV response in light of dramatic US cuts to treatment and care VANCOUVER, BC, June 6, 2025 /CNW/ - The BC Centre for Excellence in HIV/AIDS (BC-CfE) is hosting a national Summit of medical and HIV experts to raise the alarm about the rising incidence of HIV in Canada, the immense threat that US cuts to HIV programs pose to millions at risk of disease and death globally, and the need for Canadian leadership to help prevent a resurgence in HIV/AIDS. Despite the groundbreaking work done to implement the BC-CfE's Treatment as Prevention ® (TasP ®) and HIV Pre-Exposure Prophylaxis (PrEP) programs in many jurisdictions, Canada is losing ground to HIV/AIDS across the country. The latest available government statistics for 2023 show a 35% uptick in HIV cases in Canada compared to 2022. Anecdotal discussions between BC-CfE and HIV experts across Canada indicate the situation continues to deteriorate, with HIV incidence statistics expected to be higher yet again in 2024 and in 2025. Meanwhile, the United States has substantially decreased funding to domestic programs currently supported by the US Centers for Disease Control and Prevention and Medicare, and international programs supported by PEPFAR (the US President's Emergency Plan for AIDS Relief) and USAID. UNAIDS estimates another 6.6 million new HIV infections and 4.2 million AIDS-related deaths between 2025 and 2029 if US government cuts continue. At the National TasP Summit, Dr. Julio Montaner, BC-CfE Executive Director & Physician-in-Chief, called on Prime Minister Mark Carney to take the reins and redouble efforts to end the Canadian HIV/AIDS epidemic by 2030, fully fund Highly Active Antiretroviral Therapy (HAART) and PrEP within a national pharmacare plan, and meet the UNAIDS 95-95-95 target for HIV testing, treatment and viral suppression. Meeting the UNAIDS targets * would result in a 90% reduction in HIV/AIDS-related deaths and new infections by 2030, ending the HIV/AIDS epidemic as a public health threat. "The Prime Minister has called for cost-effective, nation-building projects to improve the lives of Canadians and show leadership," said Dr. Montaner. "Redoubling efforts to defeat HIV/AIDS in Canada by 2030 fits the bill. It saves lives, prevents disease progression, improves quality of life and saves money. We have a plan. We need the Prime Minister's help to get it over the finish line." In addition, Canada must step up to better support the Global Fund to Fight AIDS, Tuberculosis and Malaria, to provide much-needed international leadership in a renewed and reinvigorated fight against HIV/AIDS. Weakening global efforts for HIV prevention, treatment, and support are already having an impact in British Columbia and throughout Canada. Domestically, HIV prevention and treatment strategies have saved countless lives and dramatically improved the lives of people living with and at-risk of HIV. However, many of Canada's new HIV cases relate to domestic and international migration, demonstrating the need for federal unity in Canada's HIV response and better support for the Global Fund. "HIV does not respect provincial, Canadian or international borders," said Summit co-chair Dr. Val Montessori, BC-CfE Director of Clinical Education. "With new HIV diagnoses rising across Canada, the need is greater than ever to implement proven HIV prevention and treatment strategies. By working together, we can strengthen the national HIV response in Canada and around the world, improve the lives of people living with HIV, and prevent new cases." *About the UNAIDS 95-95-95 Targets Based on the Treatment as Prevention strategy developed by the BC-CfE, the United Nations Joint Programme on HIV/AIDS (UNAIDS) set out ambitious targets in 2014 to end the AIDS epidemic globally by 2030. This culminated in the UN 95-95-95 Targets, which established that countries ensure 95% of people living with HIV are diagnosed, 95% of those diagnosed are on treatment, and 95% of those on treatment are virally suppressed, by the year 2025. Meeting the UN Targets would change the trajectory of the epidemic so that we would see a 90% reduction in HIV/AIDS related deaths and new HIV infections by 2030, which would herald the end of the HIV/AIDS epidemic as a public health threat. About the British Columbia Centre for Excellence in HIV/AIDS The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada's largest HIV/AIDS research, treatment and education facility – nationally and internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases. The made-in-BC Treatment as Prevention ® strategy (TasP ®) pioneered by BC-CfE, and adopted by UNAIDS since 2011, inspired the ambitious global target for HIV treatment – known as the United Nations' 90-90-90 Target by 2020 and current UN 95-95-95 Target by 2025 – to end AIDS as a pandemic by 2030. The BC-CfE is applying TasP ® to therapeutic areas beyond HIV/AIDS, including viral hepatitis and addiction, to promote Targeted Disease Elimination ® as a means to contribute to healthcare sustainability. The BC-CfE works in close collaboration with key stakeholders, including government, health authorities, health care providers, academics, and the community to decrease the health burden of HIV/AIDS, hepatitis C and addictions across Canada and around the world.

HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas

Cision Canada

timea day ago

  • Cision Canada

HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas

ROTTERDAM, Netherlands, June 6, 2025 /CNW/ -- Thousands of health and technology leaders will gather to share critical health technology insights to optimize care delivery and improve health outcomes at the 2025 HIMSS European Health Conference & Exhibition from 10-12 June in Paris. HIMSS (the Healthcare Information and Management Systems Society) is a non-profit organization that serves as a global health technology advisor and thought leader dedicated to improving health through information and technology. HIMSS supports health professionals and organizations through education, professional development, networking, and digital maturity assessment tools and advisory services that help transform the global health ecosystem. At HIMSS25 Europe, powerful speakers, hands-on sessions and data-powered case studies will spur dialogue around artificial intelligence, governance, cybersecurity, workforce development, and digital maturity. Following the European conference, all eyes turn to upcoming HIMSS conferences across the globe - the 2025 HIMSS APAC Health Conference & Exhibition in July in Kuala Lumpur; and the 2026 HIMSS Global Health Conference & Exhibition in March 2026 in Las Vegas. HIMSS conferences are part of a global strategy to support healthcare organizations and professionals through a professional society of more than 125,000 members and the HIMSS digital health maturity models – internationally recognized benchmarks to assess and advise health systems in critical areas such as analytics, infrastructure, community care and EMR management. HIMSS25 Europe: Advancing AI, Health Policy and Cybersecurity HIMSS25 Europe will be the epicenter for health professionals from more than 70 countries to explore critical themes: Artificial intelligence: World-class experts will demonstrate how to effectively and ethically utilize AI in healthcare. Regulatory leadership: European officials will dive into the EU AI Act, the Cyber Resilience Act and the European Health Data Space. Cybersecurity: Attendees will learn to respond to cyber threats, safeguard patient data and ensure rapid response to cyber risks. HIMSS25 APAC: Building Momentum HIMSS25 APAC will continue the global dialogue from 16-18 July in Kuala Lumpur. HIMSS partnered with Informa Markets to co-locate its APAC conference within International Healthcare Week 2025, Southeast Asia's premier healthcare event. HIMSS25 APAC will strengthen collaboration across health ministries, private sector leaders, clinicians and technology partners. Hundreds of expert speakers will lead discussions, share solutions, and spark ideas to help shape the future of healthcare. HIMSS26: Global Health Innovation Landing in Las Vegas Co-produced with Informa Markets, the 2026 HIMSS Global Health Conference & Exhibition will convene a diverse group of digital health experts from 9-12 March 2026 in Las Vegas. HIMSS26 will feature expanded AI and cybersecurity pavilions, plus workshops on nursing informatics, workforce development, interoperability, and much more. About HIMSS HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in digital health transformation, artificial intelligence, cybersecurity, workforce development, public policy, and research to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our health innovation experts deliver key insights, education, advisory services, and engaging events to healthcare providers, payers, governments, and other health services organizations, ensuring they have the right information at the point of decision. HIMSS has served the global health community for more than 60 years, with focused operations across Americas, Europe, the United Kingdom, the Middle East and Asia-Pacific. Our members include more than 125,000 individuals and approximately 1,500 provider organizations, nonprofit partners and health services organizations. Our global headquarters is in Rotterdam, The Netherlands, and our Americas headquarters is in Chicago, Illinois. Join our global network at

Soaring beef prices push summer staples out of reach for many Canadians, study shows
Soaring beef prices push summer staples out of reach for many Canadians, study shows

CTV News

time2 days ago

  • CTV News

Soaring beef prices push summer staples out of reach for many Canadians, study shows

A new report from Dalhousie University's Agri-Food Analytics Lab says beef is quickly becoming a luxury item in Canada, with soaring prices changing the way many families approach summer barbecues. 'In Canada, beef is no longer just food—it's a financial decision." Sylvain Charlebois, the study's lead author, said. 'What was once a staple of the summer grill is now a luxury item, priced out of reach for many families.' The study points to steep price hikes since January. The cost of striploin is up 34.2 per cent, top sirloin has increased 33.7 per cent, and rib cuts have jumped nearly 12 per cent. Even pork ribs, chicken breasts and plant-based burgers have seen price increases of roughly six per cent. A shrinking cattle inventory is a key factor. Canada's beef cow population has dropped to its lowest level since 1989, with many producers exiting the industry amid volatility, according to the report. Other pressures include transportation costs, carbon pricing, labour expenses, and limited processing capacity. The report also raises concerns about a lack of regulatory scrutiny, noting that, unlike the U.S., Canadian authorities have not taken major action on possible price fixing in the beef sector. The result is Canadians are eating less beef, according to the study. Per capita consumption fell 7.1 per cent in 2023 and another 2.1 per cent this year. 'Consumers will continue to enjoy beef,' says Charlebois. 'But with moderation, and on occasions that justify the cost.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store